ERA-NET PathoGenoMics M. Karrasch, FZJ 26.09.2005 3rd Network Steering Committee Meeting 5th...

ERA-NET PathoGenoMics

M. Karrasch, FZJ26.09.2005

3rd Network Steering Committee Meeting

5th Executing Board Meeting

Workshop of Common Understanding

26th-27th September, Helsinki

(-> Agenda)

Dr. Marion Karrasch-Bott

ERA-NET PathoGenoMics - Joint Secretariat



1. News

2. Workplan

3. Deliverables and Milestones

4. Financial Summary



Uptake of the two new Hungarian Partners:

Partner 12: HAS (Hungarian Academy of Sciences)-> NSC member: Prof. Bela Nagy

-> Contact person: Dr. György Schneider

Partner 13: OTKA (Hungarian Scientific Research Fund)



PathoGenoMics brochure is now available



1. News

2. Workplan





WP 7 development of the admin. framework + Application/ evaluation system

WP 6 working group „training issues“

WP 4 SMEs/industry working group

WP 9 science and society: communication platform

WP 6 development of transnationalresearch consortia

WP 3 development of a „strategic Research Agenda“

12/2005

2005 2006

Agreement about SRA

9/2005

Agreement about admin. framework and appl./ eval. system

4/2005

2007

WP 81st

jointcall WP 8

Project execution

WP 82ndjointcall

Partne-ring Event

2004

9/2004Start

WP 1 + 2

information exchange about the national programmes

Commitment of the partners regarding joint call



12/2005

2005 2006 2007

WP 81st

jointcall WP 8

Project execution

2004

9/2004Start

Germany 12/04Spain 01/05

Austria 01/05Slovenia 04/05Finland 05/05France 05/05Israel 07/05

Portugal 08/05



Expected framework for the first joint call: 4 documents

Announcement:- english version: „skeleton“ for the national announcements; defines research topics, application/evaluation procedure etc.- specifically adapted/supplemented national versions; to be published at the same time (December 2005) in all participating countries

IPR issues: „ Information for applicants for project funding drawing up cooperation agreements on collaborative projects”

Programme/Project management description (internal document)

Guideline for evaluators

√

√



1. News

2. Workplan





Month 24 604812 36

0 24 604812 36

Timetable Deliverables: due dates

D 1.1 D 1.2 D 1.3D 2.1, 2.2, 2.3

D 3.1

D 4.1

D 5.1D 6.1

D 6.2

D 7.1, 7.2, 7.3

D 8.1

D 9.1, 9.2

D 10.1, 10.2

D 2.4

D 3.2

D 3.3D 3.3

D 4.2, 4.3

D 5.2

D 7.4D 8.1

D 8.2 D 8.2

D 8.3, 8.4D 8.3 D 8.4D 8.4

D 9.2 D 9.2 D 9.2 D 9.2 D 9.2

D 10.4D 10.3 D 10.3 D 10.3

D 10.5



Month 24 604812 36

0 24 604812 36

D 1.1

Timetable Deliverables: completion dates

D 1.2 D 1.3D 2.1, 2.2, 2.3

D 3.1

D 6.1D 6.2

D 7.1, 7.2, 7.3

D 8.1

D 9.1, 9.2

D 10.1, 10.2

D 2.4

D 3.2

D 3.3

D 5.2

D 7.4D 8.1

D 8.2 D 8.2

D 8.3, 8.4D 8.3 D 8.4D 8.4

D 9.3 D 9.3 D 9.3 D 9.3

D 10.4D 10.3 D 10.3 D 10.3

D 10.5

D 4.1

D 4.2, 4.3

D 5.1

D 3.3

D 9.3



Month

0 24 604812 36

0 24 604812 36

WP 10: M1 Constituent Assembly

WP 2: M2 Memorandum of Common Understanding

WP 4: M3 Jointly agreed innovation paper

WP 7: M4 Legal and contractual framework

WP 6: M5 European training agenda

WP 4: M6 European research agenda

WP 8: M7a Contracts 1st round

WP 8: M7b Contracts 2nd round

Timetable Milestones



1. News

2. Workplan




M. Karrasch, FZJ26.09.2005 2 4 6 8 10

4.000.000

6.000.000

2.000.000

months0

Budget

Cumulative costs per month

and average (€)

Estimated based on the costs of

AT, FI, DE, IL


M. Karrasch, FZJ26.09.2005 12 24 36 48 60

2.000.000

Budget and costs (€)

3.000.000

1.000.000

months0

Estimatedbased on the costs

of AT, FI, DE, IL, LV and ES



www.pathogenomics-era.net



Month 24 604812 36

0 24 604812 36

D 1.1


D 1.2 D 1.3D 2.1, 2.2, 2.3

D 3.1

D 6.1D 6.2

D 7.1, 7.2, 7.3

D 8.1

D 9.1, 9.2

D 10.1, 10.2

D 2.4

D 3.2

D 3.3

D 5.2

D 7.4D 8.1

D 8.2 D 8.2

D 8.3, 8.4D 8.3 D 8.4D 8.4

D 9.3 D 9.3 D 9.3 D 9.3

D 10.4D 10.3 D 10.3 D 10.3

D 10.5

D 4.1

D 4.2, 4.3

D 5.1

D 3.3

back

D 3.2: Minutes from expert workshop 1 per session (Paris, May 05) Due date: Completion date: MM 13

D 3.3: European Research Agenda 1. published draft 2. final version Due dates: 1. 2. MM 15 Approx. Completion dates: 1. MM 13 ? 2. MM 17 ?

MM 9

MM 11

D 9.3



Month 24 604812 36

0 24 604812 36

D 1.1


D 1.2 D 1.3D 2.1, 2.2, 2.3

D 3.1

D 6.1D 6.2

D 7.1, 7.2, 7.3

D 8.1

D 9.1, 9.2

D 10.1, 10.2

D 2.4

D 3.2

D 3.3

D 5.2

D 7.4D 8.1

D 8.2 D 8.2

D 8.3, 8.4D 8.3 D 8.4D 8.4

D 9.3 D 9.3 D 9.3 D 9.3 D 9.3

D 10.4D 10.3 D 10.3 D 10.3

D 10.5

D 5.1

D 3.3

Deliv.No

Deliverable name Due date (DoW)

Current status

Approx. Comple-tion

D 4.1 Strategy paper “Innovation potentials & perspectives in pathogenomics”

MM 13 1st presentation planned in MM 13

MM 17

D 4.2 Supporting network of innovation partners (PIPs) incl.minutes of 5 annual meetings (MM 15, 24, 36, 48, 60)

MM 15 1st PIP meeting planned for MM 17

MM 17

D 4.3 Web-based innovation market(including multiplication system)

MM 15 Will be delayed due to delay in D 4.1 and 4.2

back

D 4.1

D 4.2, 4.3

WP 4: Stimulating the environment for a wider exploitation and job

creation



Month 24 604812 36

0 24 604812 36

D 1.1


D 1.2 D 1.3D 2.1, 2.2, 2.3

D 3.1

D 6.1D 6.2

D 7.1, 7.2, 7.3

D 8.1

D 9.1, 9.2

D 10.1, 10.2

D 2.4

D 3.2

D 3.3

D 5.2

D 7.4D 8.1

D 8.2 D 8.2

D 8.3, 8.4D 8.3 D 8.4D 8.4

D 9.3 D 9.3 D 9.3 D 9.3

D 10.4D 10.3 D 10.3 D 10.3

D 10.5

D 4.1

D 4.2, 4.3

D 5.1

D 3.3

D 5.1: Partnering workshop in HelsinkiDue date: MM 13

current status:Planned for Feb. 06in collaboration with NoE “EuroPathogenomics”;approx. 2 months after call publication;probably not in Helsinki

back

D 9.3



Month 24 604812 36

0 24 604812 36

D 1.1


D 1.2 D 1.3D 2.1, 2.2, 2.3

D 3.1

D 6.1D 6.2

D 7.1, 7.2, 7.3

D 8.1

D 9.1, 9.2

D 10.1, 10.2

D 2.4

D 3.2

D 3.3

D 5.2

D 7.4D 8.1

D 8.2 D 8.2

D 8.3, 8.4D 8.3 D 8.4D 8.4

D 9.3 D 9.3 D 9.3 D 9.3 D 9.3

D 10.4D 10.3 D 10.3 D 10.3

D 10.5

D 4.1

D 4.2, 4.3

D 5.1

D 3.3

back

D 9.1: IT-based communication and information platform(with media service, archive, event calendars, etc.)Due date: MM 9current status:PathoGenoMics web pages publicly accessible since10th of October 2004. Communication and information platform is being programmed at the moment;will presumably be available in September 2005

D 9.2: Printed information material(e.g. teaching aids, annual reports, brochures, leaflets)Due date: MM 9Current status:First brochure about the PathoGenoMics ERA-NET is available in August 2005



Month 24 604812 36

0 24 604812 36

D 1.1


D 1.2 D 1.3D 2.1, 2.2, 2.3

D 3.1

D 6.1D 6.2

D 7.1, 7.2, 7.3

D 8.1

D 9.1, 9.2

D 10.1, 10.2

D 2.4

D 3.2

D 3.3

D 5.2

D 7.4D 8.1

D 8.2 D 8.2

D 8.3, 8.4D 8.3 D 8.4D 8.4

D 9.3 D 9.3 D 9.3 D 9.3

D 10.4D 10.3 D 10.3 D 10.3

D 10.5

D 4.1

D 4.2, 4.3

D 5.1

D 3.3

D 9.3

back

D 9.3: On-spot presentations(annually, at special events)Due dates: MM 10, 19, 32, 43, 55)

Completion dates: ?



Deliv.No Deliverable name Due date (DoW)

Current status Approx. Comple-tion


MM 13 1st presentation planned in MM13

MM 17



MM 17



back



Deliv. No



Submission to EC

D 5.1 Partnering workshop in Helsinki(about 200 persons, 2 days)

MM 13 Planned for Feb. 06 in collaboration with NoE “EuroPatho-genomics”; approx. 2 months after call publication; probably not in helsinki

MM 17

back



Deliv.No


Current status Comple-tion

Submission to EC

D 1.1 Agreement on programme data to be collected incl. standard format for data exchange/processing

MM 1 completed MM 3 MM 7(1st Mar 2005)

D. 1.2 Information documents on the national programmes (one per partner)

MM 5 completed MM 7 MM 12(16th Aug 2005)

D 1.3 Interactive Information System on Pathogenomics (IISP)

MM 9 completed MM 2MM 11

MM 12(16th Aug 2005)

D 2.1 Documentations to national programmes in third countries


D 2.2 Compilation of international cooperations between European and third countries


D 2.3 Report “Future trends & challenges in pathogenomics“(as result of a foresight study)


D 2.4 Workshop for common understanding plus related printed information materials (brochures, leaflets)


D 3.1 Minutes from “kick-off” starting meeting


D 3.2 Minutes from expert workshops (one per session)

MM 9 workshop took place 23rd to 25th of May 2005 in Paris; Minutes will be delivered by P5 (MRNT), France, approx. in xx 2005

MM 12

D 3.3 European Research Agenda(1. published draft, 2. final version)

MM 11, 15 MM 11



Deliv.No



Submission to EC


MM 13 1st presentation planned in MM13

MM 17



MM 17



D 5.1 Partnering workshop in Helsinki(about 200 persons, 2 days)

MM 13 Planned for Feb. 06 with NoE

MM 17

D 5.2 Satellite workshop to 2nd FEMS conference in Spain(July 2006, about 200 persons, 1 day)

MM 23

D 6.1 Summer schools, transnational Ph.D. supervision, joint seminars, and other specific training measures

From MM 13

D 6.2 Integration of PathoGenoMics at the European Researchers Mobility Portal

MM 15

D 7.1 Guidelines for proposers and evaluators;joint evaluation system including administration tools

MM 13 MM 13

D 7.2 Transnational expert/adviser database MM 13

D 7.3 Legal and contractual framework (i.e. contract, cooperation agreement, funding scheme)

MM 13 Agreement on 3rd NSC meeting planned

MM 13

D 7.4 Transnational task force of programme managers from MM 14 See D 7.3 MM 13



Deliv.No



D 8.1 Publication of 2 synchronised, specifictransnational calls

MM 16, 28 Publication of the first joint call scheduled for December 2005

MM 16

D 8.2 2 evaluation sessions incl. priority lists

MM 22, 34 Deadline for proposal submission scheduled for April 2006, evaluation will take place April to June 2006

MM 22

D 8.3 Selected proposals and funding contracts

MM 24, 36 Funding decision scheduled for July 2006 MM 3

D 8.4 Periodical project reports (annually)

MM 36, 48,60

D 9.1 IT-based communication and information platform(with media service, archive, event calendars, etc.)

MM 9 PathoGenoMics web pages publicly accessible since 10th of October 2004.Communication and information platform is programmed at the moment; will presumably be available in September 2005

D 9.2 Printed information materials(i.e. teaching aids, annual reports, brochures, leaflets)

MM 9 First brochure about the PathoGenoMics ERA-NET is available in August 2005

D 9.3 On-spot presentations(annually, at special events)

MM 10, 19, 32, 43, 55



Deliv.No

Deliverable name

Due date

Current status Comple-tion

Submission to EC

D 10.1 Joint Secretariat MM 4 Joint Secretariat was established on 1st of September 2004.

MM 1 MM 3(15th Nov 2004)

D 10.2 Electronic Management and Information System

MM 4 PathoGenoMics web pages publicly accessible since 10th of October 2004.Web-based management- and information tool available since 25th of February, 2005

MM 2MM 6

MM 7(1st Mar 2005)

D 10.3 Consortium management reporting(progress and financial reports, audit certificates)

MM 12, 24, 36, 48, 60

Consortium management reporting submitted 11/04, 03/05, 08/05

Financial report and audit certificates due in MM 18, 36 and 60

MM 2, MM 7, MM 12

D 10.4 Consortium agreement

MM 1 The signed Agreements were returned to the Coordinator between November 2004 and February 2005 (last Agreement arrived on 21st February at the Coordinator) (except Hungary)

MM 6 MM 7(1st Mar 2005)

D 10.5 NSC and EB meetings incl. quarterly circulars

MM 1, 3, 6, 9, 12, ..., 60

The 1st NSC meeting and the 1st EB meeting: 13th – 15th October 2004 in BerlinThe 2nd EB meeting: 20th January in Bonn, Germany The 3rd EB/ 2nd NSC meeting: 7th/8th of April in Bonn, GermanyThe 4th EB meeting: 27th/28th of June in Vienna, Austria The 5th EB/ 3rd NSC meeting: 26th/27th of September in Helsinki, Finland

MM 2

MM 5

MM 8

MM 10

MM 3(15th Nov 2004)MM 7(1st Mar 2005)MM 12(16th Aug 2005)MM 12(16th Aug 2005)



Year DueMonth

Number

Specification Current status Approx. completion

Submission to EC

1 MM 1 M 1 Constituent Assembly to establish project bodies

Constituent Assembly held on 13th to 15th October 2004 in Berlin, Project Bodies have been established

CompletedMM 2

MM 3(15th Nov 2004)

MM 6 M 2 Memorandum of Common Understanding

Completed on the NSC/EB meeting on the 7th and 8th April 2005 in Bonn

CompletedMM 8

MM 12(16th August 2005)

2 MM 13

M 3 jointly agreed Innovation Strategy Paper

MM 18

MM 13

M 4 jointly agreed Legal & Contractual Framework for Joint Calls

MM 13

MM 13

M 5 jointly agreed European Training Agenda

MM 13

MM 15

M 6 Jointly agreed European Research Agenda

MM 13

MM 24

M 7a Contracts, 1st round of Joint Calls

MM 22

3 MM 36

M 7b Contracts, 2nd round of Joint Calls

MM 34

Milestones



MONDAY, September 26, 2005 Conference Centre Paasitorni, meeting room “Juho Rissanen” (2nd floor)

9:30-9.40 Welcome

9.40-10.00 The current ERA-Net status and the planning of FP 7 (Giorgio Clarotti, Scientific Officer, European Commission)

10:00-10:10 ERA-NET PathoGenoMics: Current status. (Marion Karrasch, ERA-NET PathoGenoMics Secretariat)

10:10-10:30 A summary of the expert workshop on the European Research Agenda (WP 3) (Philippe Glaser, Instutut Pasteur, France)

10:30-10:50 Coffee

10:50-11:10 General information on the Network of PathoGenoMics innovation partners (WP 4) (Kathleen Victoir, Institut Pasteur, France)

11:10-11:40 A summary of the call text and the IPR issues. Decisions on the open parts of the call text (dates, other)

11:40-12:00 Decisions on the call text and the IPR issues

– Memorandum of common understanding

12:00-13:00 Lunch

13:00-14:30 Implementation of the joint call:

- Evaluation criteria/guidelines of proposals submitted

- Internal programme management procedure

- Nomination of the Scientific Advisory Board members for the evaluation of the proposals

- Discussion on the application forms

14:30-14:50 Coffee

14:50-17:00 Implementation of the joint call (continues)

Agenda September 26-27, 2005 Helsinki, Finland

.

back



Agenda September 26-27, 2005 Helsinki, Finland

TUESDAY, September 27, 2005 Conference Centre Paasitorni, meeting room “Juho Rissanen” All participants are welcome to attend the NSC and the EB meetings

3rd Network Steering Committee (NSC) meeting

9:00-9:40 - Chair for the NSC for the 2nd year - Preparation of the meeting to be held in Jerusalem in the spring 2006 - Other issues

5th Executing Board (EB) meeting

9:40-10:30 - Administrative issues: financial status

- The current status of the on-going activities WP5: Preparation of the Partnering Event

WP6: Training and mobility

WP9: Science and society - Other issues

10:30-10.45 Coffee

10.45-12.15 EB Meeting (continues)

12:15-13:00 Lunch break

13:00-14:00 EB Meeting (continues, if needed)

ERA-NET PathoGenoMics M. Karrasch, FZJ 26.09.2005 3rd Network Steering Committee Meeting 5th...

Documents

Transcript of ERA-NET PathoGenoMics M. Karrasch, FZJ 26.09.2005 3rd Network Steering Committee Meeting 5th...